Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 7/20 | 0.36 |
| ▸ | BCAT2 | O15382 | 5/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PPOX | P50336 | 2/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | UGCG | Q16739 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2594502 | 0.92 | BCAT1 (0.41) | BCAT1BCAT2PPOXMAT2AMAPK8 | |
| SCHEMBL26017381 | 0.91 | BCAT1 (0.35) | BCAT1BCAT2PPOXMAT2AMAPK8 | |
| SCHEMBL121222 | 0.90 | PPOX (0.41) | BCAT1BCAT2KMT2APPOXALDH1A1 | |
| SCHEMBL29351496 | 0.90 | PPOX (0.41) | BCAT1BCAT2KMT2APPOXALDH1A1 | |
| Benzene SCHEMBL21843346 | 0.90 | BCAT1 (0.34) | BCAT1BCAT2KMT2AMAT2AMEN1 | |
| SCHEMBL1959750 | 0.90 | BCAT1 (0.34) | BCAT1BCAT2KMT2AMAT2AMEN1 | |
| SCHEMBL29709277 | 0.90 | BCAT1 (0.34) | BCAT1BCAT2KMT2AMAT2AMEN1 | |
| SCHEMBL12029834 | 0.90 | UGCG (0.33) | BCAT1BCAT2MAPK8CYP3A4UGCG | |
| SCHEMBL22356179 | 0.90 | UGCG (0.33) | BCAT1BCAT2KMT2APPOXSCN9A | |
| SCHEMBL21616077 | 0.89 | PPOX (0.40) | BCAT1BCAT2KMT2APPOXL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820755-B2 | Uracil compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-21 | — | — | US | disclosed |
| US-11820755-B2 | Uracil compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-21 | — | — | US | disclosed |
| US-20210122731-A1 | URACIL COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-04-29 | — | — | US | disclosed |
| US-10966427-B2 | 3-pyridyl oxyanilide compound and use therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20200120934-A1 | 3-PYRIDYL OXYANILIDE COMPOUND AND USE THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-04-23 | — | — | US | disclosed |
| WO-2020009193-A1 | URACIL COMPOUND AND USE THEREOF | 住友化学株式会社 | 2020-01-09 | — | — | WO | disclosed |
| WO-2018114759-A1 | PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES | BASF Agro B.V. (NL) | 2018-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122731-A1 | URACIL COMPOUND AND USE THEREOF | UNG, UMPS, UGP2 | BCAT1 243/4885BCAT2 278/4885KMT2A 1873/4885 |
| US-20200120934-A1 | 3-PYRIDYL OXYANILIDE COMPOUND AND USE THEREFOR | NOTUM, WEE2, WEE1 | BCAT1 1081/4885BCAT2 1101/4885KMT2A 1331/4885 |
| US-10966427-B2 | 3-pyridyl oxyanilide compound and use therefor | NOTUM, WEE2, WEE1 | BCAT1 1081/4885BCAT2 1101/4885KMT2A 1331/4885 |
| US-11820755-B2 | Uracil compound and use thereof | UNG, UMPS, UGP2 | BCAT1 243/4885BCAT2 278/4885KMT2A 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.